MARKET

VANI

VANI

Vivani Medical
NASDAQ
1.200
+0.060
+5.26%
Closed 16:39 06/26 EDT
OPEN
1.150
PREV CLOSE
1.140
HIGH
1.215
LOW
1.150
VOLUME
164.56K
TURNOVER
0
52 WEEK HIGH
1.920
52 WEEK LOW
0.9228
MARKET CAP
103.48M
P/E (TTM)
-2.9528
1D
5D
1M
3M
1Y
5Y
1D
Vivani Medical files Form 3 for director August J. Moretti
PUBT · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Avita Medical (RCEL), Vivani Medical (VANI)
TipRanks · 2d ago
Vivani Medical names August Moretti to board as Dean Baker retires
PUBT · 2d ago
*Vivani Medical Announces Appointment of August Moretti to Board, Retirement of Dean Baker
Dow Jones · 2d ago
Press Release: Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
Dow Jones · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
Reuters · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne
Reuters · 3d ago
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.